Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases
NCT05129202
·
clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
immune therapy
Sponsor
Hunan Province Tumor Hospital